Skip to content
The Policy VaultThe Policy Vault

Mekinist (trametinib tablets and oral solution – Novartis) — Cigna

Histiocytic Neoplasm

Initial criteria

  • Patient has Langerhans cell histiocytosis OR
  • Patient has Erdheim-Chester disease; OR
  • Patient has Rosai-Dorfman disease.

Approval duration

1 year